Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.

Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type 1 ...

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court ...

BEIJING - Sinovac Biotech Ltd. (NASDAQ:SVA), a prominent biopharmaceutical company in China with a market capitalization of $45.31 million, has confirmed the implementation of a court order ...

BEIJING, February 28, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC ...

Sinovac Biotech (SVA) announced that Sinovac has received a formal court order from the Privy Council following the previously announced Privy Council Judgment which ruled, among others ...

BEIJING — Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company“), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a ...

O acordo para liberação da unidade foi assinado na sexta-feira, 21, com a biofarmacêutica chinesa Sinovac Biotech, responsável por desenvolver o primeiro imunizante contra a Covid-19 oferecido no ...

FILE-A technician works in a lab at Sinovac Biotech where the company is producing their potential COVID-19 vaccine CoronaVac during a media tour on September 24, 2020 in Beijing, China.

A distinct coronavirus lineage was found in bats in Hong Kong. HKU5-CoV-2 carries a risk of animal-to-human transmission and binds to humans like the virus that causes COVID-19. Researchers ...